a

Facebook

Twitter

Copyright 2017 Black Soul Science.
All Rights Reserved.

1:00 - 5:00pm (CT)

Hours of Phone Operation Mon. - Fri.

313.473.9776

Contact

Facebook

Twitter

Search
Menu
 

March 2017

Black Soul Science > 2017 > March (Page 20)

Andrew Napolitano returns to Fox News, stands by false spying claim

[ad_1] Fox News analyst Andrew Napolitano is standing by his claim, still without evidence, that former President Obama worked with British intelligence officials to spy on Donald Trump. Napolitano returned to Fox News airwaves on Wednesday morning after a week-long absence and said he stood by his claim that Obama "went outside the chain of command" and used the UK's GCHQ service to surveil then-President-elect Trump. GCHQ has categorically denied Napolitano's allegation, calling it "utterly ridiculous." Fox News has also said it has...

Continue reading

CNN panel clashes over Spicer's admonition to April Ryan

[ad_1] CNN panelists clashed Tuesday night over an earlier exchange between White House Press Secretary Sean Spicer and longtime White House correspondent April Ryan. "April Ryan's only crime today, if you will, was being a black woman at work and Sean Spicer could not handle that," CNN contributor Symone Sanders said on "CNN Tonight," drawing an eruption of both protest and agreement from her fellow panelists. "Please, give me a break," fired back CNN political commentator Ben Ferguson. "That's absurd. That's insanity, that's...

Continue reading

FDA Approves 1st Drug For Aggressive Multiple Sclerosis

[ad_1] TRENTON, N.J. (AP) — U.S. regulators have approved the first drug for an aggressive kind of multiple sclerosis that steadily reduces coordination and the ability to walk. The Food and Drug Administration approved Ocrevus late Tuesday after a large study found it slowed progression of the neurological disease and reduced symptoms. While there are more than a dozen treatments for the most common form of MS, there’s been nothing specifically for people with the type called primary progressive MS. That type of MS is relatively rare, affecting about 50,000 Americans. The drug was also approved for relapsing forms of MS, which progress...

Continue reading